Teladoc Health Inc (TDOC) concluded trading on Wednesday at a closing price of $7.79, with 4.99 million shares of worth about $38.89 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.14% during that period and on April 03, 2025 the price saw a gain of about 0.39%. Currently the company’s common shares owned by public are about 173.41M shares, out of which, 171.88M shares are available for trading.
Stock saw a price change of -9.84% in past 5 days and over the past one month there was a price change of -15.33%. Year-to-date (YTD), TDOC shares are showing a performance of -14.30% which decreased to -47.54% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.76 but also hit the highest price of $15.21 during that period. The average intraday trading volume for Teladoc Health Inc shares is 7.59 million. The stock is currently trading -8.92% below its 20-day simple moving average (SMA20), while that difference is down -23.29% for SMA50 and it goes to -16.68% lower than SMA200.
Teladoc Health Inc (NYSE: TDOC) currently have 173.41M outstanding shares and institutions hold larger chunk of about 73.67% of that.
The stock has a current market capitalization of $1.35B and its 3Y-monthly beta is at 1.83. It has posted earnings per share of -$5.88 in the same period. It has Quick Ratio of 1.69 while making debt-to-equity ratio of 1.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TDOC, volatility over the week remained 5.02% while standing at 5.15% over the month.
Stock’s fiscal year EPS is expected to rise by 83.91% while it is estimated to increase by 9.84% in next year. EPS is likely to grow at an annualized rate of 49.20% for next 5-years, compared to annual growth of -33.66% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on November 15, 2024 offering a Buy rating for the stock and assigned a target price of $14 to it. Coverage by Jefferies stated Teladoc Health Inc (TDOC) stock as a Hold in their note to investors on September 17, 2024, suggesting a price target of $10 for the stock. On February 29, 2024, Cantor Fitzgerald Initiated their recommendations, while on February 26, 2024, Leerink Partners Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from DA Davidson on January 17, 2024.
